BRINSUPRI (BRENSOCATIB 10MG / 25MG )
Price
FAQ's
Details
Patients Stories
Important Guide
Brensocatib is a first-in-class DPP-1 inhibitor used for the treatment of non-cystic fibrosis bronchiectasis. It reduces neutrophil-mediated inflammation in the airways, helping decrease pulmonary exacerbations and preserve lung function over time.

